{"disease":{"id":"eye-disorders","name":"eye disorders"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04428541","title":"Determination of the Validity of a Questionnaire to Assess the Visual Function of Preverbal Children With Operable Bilateral Ocular Pathologies","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT07443683","title":"Does Orientation On Eye Health To Female Health Volunteers Increase Footfall In A Vision Center","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":149,"lead_sponsor_name":"Seva Canada Society","has_results":false},{"nct_id":"NCT06985264","title":"Dry Eye in Upper Eyelid Surgery: Muscle Versus Fat Removal","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":142,"lead_sponsor_name":"Mersin Training and Research Hospital","has_results":false},{"nct_id":"NCT03396627","title":"Müller's Muscle as a New Proprioceptive Organ","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT03872479","title":"Single Ascending Dose Study in Participants With LCA10","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"Editas Medicine, Inc.","has_results":false},{"nct_id":"NCT05945069","title":"Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects with Dry Eye Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Lumenis Be Ltd.","has_results":false},{"nct_id":"NCT03396042","title":"Natural History Study of CEP290-Related Retinal Degeneration","phase":"","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Editas Medicine, Inc.","has_results":false},{"nct_id":"NCT06451172","title":"Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT03780257","title":"Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"ProQR Therapeutics","has_results":false},{"nct_id":"NCT04123626","title":"A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":11,"lead_sponsor_name":"ProQR Therapeutics","has_results":false},{"nct_id":"NCT03913130","title":"Extension Study to Study PQ-110-001 (NCT03140969)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Laboratoires Thea","has_results":true},{"nct_id":"NCT05158296","title":"Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Laboratoires Thea","has_results":true},{"nct_id":"NCT04377893","title":"Applying Eye-Gaze Assistive Technology for Children and Youth With Complex Needs","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Yu-Hsin Hsieh","has_results":false},{"nct_id":"NCT05176717","title":"Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Laboratoires Thea","has_results":true}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}